Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema

CMAJ. Canadian Medical Association Journal

Volumn 185, Issue 9, 2013, Pages 791-792

  Rizk, Caroline ^a   Karsh, Jacob ^a   Santucci, Stephanie ^b   Yang, William ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ECALLANTIDE; ICATIBANT;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; AUTOSOMAL DOMINANT DISORDER; CATHETER INFECTION; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DERMATOLOGY LIFE QUALITY INDEX; DISEASE CONTROL; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG SELF ADMINISTRATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOSPITAL ADMISSION; HUMAN; INDWELLING CATHETER; LARYNX EDEMA; PATIENT EDUCATION; QUALITY OF LIFE; SEPSIS; SHORT FORM 36; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN EDEMA; TREATMENT DURATION; VEIN PUNCTURE;

EID: 84878893497     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.121364     Document Type: Article

References (7)

1. Zuraw BL. Hereditary angioedema. N Engl J Med 2008; 359: 1027-36.
2. Farkas H, Jakab L, Temesszentandrási G, et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 2007;120:941-7. (Pubitemid 47531846)
3. Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol 2007;147:11-7. (Pubitemid 44915550)
4. Levi M, Choi G, Picavet C, et al. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006; 117: 904-8.
5. Rooden CJ, Tesselaar MET, Osanto S, et al. Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost 2005;3:2409-19. (Pubitemid 41727156)
6. Bygum A, Andersen KE, Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol 2009; 19: 147-51.
7. Rodríguez M, Procupet A, Heras J. Cost-effectiveness analysis of home administration versus hospital administration of intravenous immunoglobulin. Med Clin (Barc) 1991; 96: 47-51.